PROGNOSTIC VALUE OF ADDITIONAL CHROMOSOMAL ABERRATIONS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA ON TYROSINEKINASE INHIBITORS THERAPY

PROGNOSTIC VALUE OF ADDITIONAL CHROMOSOMAL ABERRATIONS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA ON TYROSINEKINASE INHIBITORS THERAPY

Prognostic significance of additional chromosomal abnormalities (ACAs) for tyrosinekinase inhibitors therapy (TKI) response in chronic myeloid leukemia (CML) patients is discussed. In many ways, this uncertainty is dueto the low frequency as well as the high variability of ACAs in patients with chro...

Full description

Bibliographic Details
Main Authors:	Dmytrenko I. V., Minchenko Zh. M., Fedorenko V. G., Dyagil I. S.
Format:	Article
Language:	English
Published:	Ukrainian Medical Stomatological Academy 2019-04-01
Series:	Вісник проблем біології і медицини
Subjects:	chromosomal aberrations chronic myeloid leukemia prognostic factors resistance tyrosine kinase inhibitors.
Online Access:	https://vpbm.com.ua/upload/2019-2-1/51-min.pdf

Similar Items

SIGNIFICANCE OF ADDITIONAL CHROMOSOMAL ABNORMALITIES FOR THE OUTCOMES AFTER THE SECOND LINE NILOTINIB THERAPY IN THE CHRONIC MYELOID LEUKEMIA PATIENTS
by: I. V. Dmytrenko, et al.
Published: (2019-07-01)

Complex karyotype including ring chromosome 11 in a patient with acute myeloid leukemia: case report
by: Maria Helena Faria Ornellas, et al.
Published: (2017-08-01)

Higher frequencies of chromosomal aberrations in lymphocytes of children with acute lymphoblastic leukemia after in vitro gamma irradiation
by: Azimi C, et al.
Published: (2012-12-01)

Molecular and cytogenetic abnormalities in acute myeloid leukemia: review and case studies
by: Elvira Deolinda Rodrigues Pereira Velloso, et al.
Published: (2011-06-01)

Prognostic value of myeloid antigens expression in childhood acute lymphoblastic leukemia
by: Aula Mahmood Ibrahim, et al.
Published: (2017-01-01)

Aberrant Phenotype in Iranian Patients with Acute Myeloid Leukemia
by: Mehdi Jahedi, et al.
Published: (2014-03-01)

Atypical chromosome abnormalities in acute myeloid leukemia type M4
by: Agnes C. Fett-Conte, et al.
Published: (2007-01-01)

Features of the etythropoesis upon treatment of chronic myeloid leukemia with tyrosine kinase inhibitor
by: I. Sviezhentseva, et al.
Published: (2016-07-01)

Prognostic Factors for Overall Survival In Chronic Myeloid Leukemia Patients: A Multicentric Cohort Study by the Italian CML GIMEMA Network
by: Giorgina Specchia, et al.
Published: (2021-08-01)

Chronic myeloid leukemia (CML): prognostic factors and survival analysis
by: Gisele Wally Braga, et al.

Use of tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia (CML)
by: C. B. Almeida, et al.
Published: (2016-11-01)

Karyotype abnormalities and their clinical significance in a group of chronic myeloid leukemia patients treated with hematopoietic stem cell transplantation
by: Luize Otero, et al.

Additional chromosome abnormalities in chronic myeloid leukemia
by: Hui-Hua Hsiao, et al.
Published: (2011-02-01)

Aberrant Phenotypes in Acute Myeloid Leukemia and Its Relationship with Prognosis and Survival: A Systematic Review and Meta-Analysis
by: Lucio Henrique Sousa Pinheiro, et al.
Published: (2020-10-01)

A Bone Marrow Study; Report of Chromosomal Variations in Hematologic Malignancies Including Acute Myeloid Leukemia, Acute Lymphoid Leukemia, and Myelodisplastic Syndrome (Northeast Iran)
by: Sepideh Shakeri, et al.
Published: (2021-07-01)

Characterization of Common Chromosomal Translocations and Their Frequencies in Acute Myeloid Leukemia Patients of Northwest Iran
by: Elnaz Amanollahi Kamaneh, et al.
Published: (2016-04-01)

Comparative evaluation of bone marrow cells morpho-functional activity in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors of the first and second generation
by: I. O. Zhaleyko, et al.
Published: (2014-07-01)

Change of concentration of biochemical markers of dysfunction of endothelium at intake of inhibitors of tyrosinekinase of I and II generations at patients with a chronic myeloid leukemia as risk factor of development of cardiovascular complications
by: K. V. Naumova, et al.
Published: (2021-01-01)

Successful treatment with ABL tyrosine kinase inhibitor for patients with acute myeloid leukemia with BCR-ABL1
by: Asako Takeuchi, et al.
Published: (2021-01-01)

CYTOGENETIC FINDINGS IN ACUTE MYELOID LEUKEMIA
by: Gh. Toogeh, et al.
Published: (2003-08-01)

CYTOGENETIC FINDINGS IN ACUTE MYELOID LEUKEMIA
by: Gh. Toogeh, et al.
Published: (2003-12-01)

CEBPE expression is an independent prognostic factor for acute myeloid leukemia
by: Kening Li, et al.
Published: (2019-06-01)

Chromosome aberration in azoospermias
by: Wahyuning Ramelan
Published: (1993-02-01)

Molecular genetic and cytogenetic determinants of primary resistance or loss of the response to treatment with tyrosine kinase inhibitors in patients with chronic myeloid leukemia.
by: Kotlyarchuk K., et al.
Published: (2015-09-01)

Molecular genetic and cytogenetic determinants of primary resistance or loss of the response to treatment with tyrosine kinase inhibitors in patients with chronic myeloid leukemia.
by: K. Kotlyarchuk, et al.
Published: (2015-09-01)

Success and Challenges in the Management of Chronic Myeloid Leukemia
by: Anil Kumar Tripathi
Published: (2019-07-01)

TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
by: Michele Baccarani, et al.
Published: (2014-01-01)

An unusual association of Morning Glory Syndrome with chronic myeloid leukemia-Philadelphia chromosome
by: Rakesh Panyala, et al.
Published: (2020-01-01)

Systematic Construction and Validation of an RNA-Binding Protein-Associated Prognostic Model for Acute Myeloid Leukemia
by: Hongwei Luo, et al.
Published: (2021-09-01)

Influence of different chromosomal abnormalities in Ph-positive bone marrow cells on the chronic myeloid leukemia course during tyrosine kinase inhibitors therapy
by: O. Yu. Vinogradova, et al.
Published: (2014-07-01)

Influence of different chromosomal abnormalities in Ph-positive bone marrow cells on the chronic myeloid leukemia course during tyrosine kinase inhibitors therapy
by: O. Yu. Vinogradova, et al.
Published: (2014-07-01)

Is Flow Cytometric Immunophenotyping Useful for Predicting Acute Myeloid Leukemia Prognosis?
by: Hava Üsküdar Teke, et al.
Published: (2017-12-01)

Induced and spontaneous chromosomal aberrations in cultured human leukocytes
by: Andrews, John Charles
Published: (2011)

Turning Stem Cells Bad: Generation of Clinically Relevant Models of Human Acute Myeloid Leukemia through Gene Delivery- or Genome Editing-Based Approaches
by: Maria Mesuraca, et al.
Published: (2018-08-01)

Genetic Mutations in Acute Myeloid Leukemia
by: OV Blau
Published: (2016-07-01)

Chromosomal Instability in Acute Myeloid Leukemia
by: Mateus de Oliveira Lisboa, et al.
Published: (2021-05-01)

Transformation of Acute Myeloid Leukemia with Deletion of Chromosome 7q and Additional Abnormalities in Chromosome 8 in a Patient with Essential Thrombocythemia
by: Ayaka Shimizu, et al.
Published: (2021-03-01)

Mixed phenotype acute leukemia with t(9;22): success with nonacute myeloid leukemia-type intensive induction therapy and stem cell transplantation
by: Chan, Onyee, et al.
Published: (2017)

Nilotinib for the frontline treatment of chronic myeloid leukemia carrying the p230 transcript: dream or reality?
by: Maurizio eCapuozzo, et al.
Published: (2014-02-01)

Chronic myeloid leukemia: In pursuit of perfection
by: Vishal Jayakar
Published: (2012-07-01)

Cannot write session to /tmp/vufind_sessions/sess_o1gm3qttqedeevuob6attn4p9b